Methyl 5-hydroxy-2-nitrobenzoate

Catalog No. :
ACADRX215
CAS No. :
59216-77-2
Molecular Formula :
C8H7NO5
Molecular Weight :
197.15

IUPAC Name:methyl 5-hydroxy-2-nitrobenzoate

Methyl 5-hydroxy-2-nitrobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$65.00Login to see priceIn stockIn stock
5g97%$171.00Login to see priceIn stockIn stock
10g97%$323.00Login to see priceInquiryIn stock
25g97%$753.00Login to see priceInquiryInquiry
100g97%$2381.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-hydroxy-2-nitrobenzoate
IUPAC Namemethyl 5-hydroxy-2-nitrobenzoate
MDL No.MFCD00100487
Molecular FormulaC8H7NO5
Molecular Weight197.15
SMILESO=C(OC)C1=CC(O)=CC=C1[N+]([O-])=O
InChI KeyVYLLCOXNYMTKMD-UHFFFAOYSA-N
SynonymMETHYL 5-HYDROXY-2-NITROBENZOATE;RARECHEM AL BF 0679;5-Hydroxy-2-nitro-benzoic acid methyl ester;Benzoic acid, 5-hydroxy-2-nitro-, methyl ester;2-Nitro-5-hydroxybenzoic acid methyl ester
CAS No.59216-77-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACADRX215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACSIXL374 route compound structure diagram
    ACSIXL374610-37-7 In Stock
  4. Then
  5. ACADRX215 route product structure diagram
    ACADRX21559216-77-2 In Stock
Inquiry

2. ACADRX215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSIXL374 route compound structure diagram
    ACSIXL374610-37-7 In Stock
  2. Then
  3. ACADRX215 route product structure diagram
    ACADRX21559216-77-2 In Stock
Inquiry

Comments (0)